LED Medical Announces US Distribution Agreement with Burkhart Dental Supply
03 Dicembre 2013 - 3:25PM
Marketwired
LED Medical Announces US Distribution Agreement with Burkhart
Dental Supply
BURNABY, BRITISH COLUMBIA--(Marketwired - Dec 3, 2013) - LED
Medical Diagnostics Inc. ("LED Medical, the Company")
(TSX-VENTURE:LMD) (OTCQX:LEDIF) (FRANKFURT:LME) is pleased to
announce that its wholly‐owned subsidiary, LED Dental Inc., has
entered into a non‐exclusive partnership with Burkhart Dental
Supply ("Burkhart") for the distribution of the company's VELscope®
Vx Enhanced Oral Assessment System and product line within the
United States market.
"We are pleased to
partner with Burkhart, one of the most respected dental supply
companies in the United States," stated Dr. David Gane, CEO for LED
Medical. "For over 125 years Burkhart has been committed to serving
dental practitioners with quality equipment and supplies,
comprehensive product training, as well as strong after‐sales
support. Their strong market presence and deep network is ideally
suited to our expansion strategy for the VELscope® Vx product line
in the United States."
"We are pleased to
carry the VELscope Vx product line for our US network," states Lori
Burkhart Isbell, President of Burkhart. "The VELscope® Vx sets the
standard for tissue fluorescence visualization and is a market
leading adjunctive oral mucosal examination tool that is in demand
with our client base. It has also proven to be highly effective for
the early detection of oral cancer and pre‐cancers, and we support
it as an important, potentially life‐saving device."
About the VELscope®
Vx Enhanced Oral Assessment System
The distinctive
blue‐spectrum light of the VELscope® Vx hand‐held device causes the
soft tissues of the mouth to naturally fluoresce. Healthy tissues
fluoresce in distinct patterns that are visibly disrupted by trauma
or disease, such as neoplastic lesions, chemical irritation,
side‐effects from medication, thermal damage, fungal, viral or
bacterial infections. Use of the VELscope® Vx allows a wide variety
of oral abnormalities to be discovered, often before they're
visible to the unassisted eye. It is also the only tissue
fluorescence device with photo/video documentation capabilities
through the viewing mechanism, a key function for referrals and
patient records.
About Burkhart
Dental Supply
Since 1888, the
people of Burkhart have helped dentists achieve personal and
professional success through the provision of equipment, repairs,
supplies, and consulting. Through integrity, personal service and a
commitment to its client's best interest, Burkhart has built a
strong distribution network serving more than 5,000 dental
practitioners. For more details, visit www.burkhartdental.com.
About LED Medical
Diagnostics Inc.
Founded in 2003 and
headquartered in Burnaby, British Columbia, Canada, LED Medical
Diagnostics Inc. is a leading developer of LED‐based visualization
technologies for the medical industry. The Company is currently
listed on the Toronto Stock Exchange (TSX‐V) under the symbol
"LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt
Stock Exchange under the symbol "LME". For more information, visit
www.ledmd.com.
Through its
wholly‐owned subsidiary, LED Dental Inc., the company manufactures
the VELscope® Vx Enhanced Oral Assessment System, the first system
in the world to apply tissue fluorescence visualization technology
to the oral cavity. VELscope® Vx devices are now used to conduct
more screenings for oral cancer and other oral diseases than any
other adjunctive device. To date, there have been more than 12,000
VELscope® Vx systems sold globally and they have been used to
perform more than 25 million exams. For more information, call
604.434.4614 or visit www.leddental.com.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
LED Medical Diagnostics Inc.Mark Komonoski, Investor
Relations(403) 255-8483 or Toll-Free: (877) 255-8483Cell: (403)
470-8384mark.komonoski@ledmd.comSkype: mkomonoski
Grafico Azioni LED Medical Diagnostics (TSXV:LMD)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni LED Medical Diagnostics (TSXV:LMD)
Storico
Da Feb 2024 a Feb 2025
